Hold Rating Recommended Amid Competitive Bidding War for Revance Therapeutics
Needham analyst Serge Belanger has maintained their neutral stance on RVNC stock, giving a Hold rating on January 13.Stay Ahead of the ...
Aesthetic Injectable Market Expected to Reach USD 18.12 Billion by 2032, with a CAGR of 7.5% | Introspective Market Research
Allergan Aesthetics, an AbbVie company, introduced AMI Business Education, a new addition to its AMI Online platform.